Chinese management guidelines for radioactive iodine-refractory differentiated thyroid cancer (2025 edition).

Purpose: Radioactive iodine-refractory differentiated thyroid cancer (RAIR-DTC) has become a challenge in clinical practice, particularly in China with a high incidence and undesirable survival outcome. Since the publication of first China consensus on the diagnosis and treatment of RAIR-DTC in 2019...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 52; no. 10; pp. 3859 - 3877
Autores principales:	Lin, Yan-Song, Wang, Ren-Fei, Huang, Rui, Wen, Qiang, Cao, Wei, Chen, Li-Bo, Guo, Ye, Hou, Xiao-Rong, Li, Li, Li, Xiao-Yi, Lin, Cheng-He, Liu, Zhi-Yan, Wang, Hao, Wang, Xu-Fu, Wang, Zhuo-Ying, Wu, Xiao-Hong, Xu, Shu-Hang, Yang, Ai-Min, Zhang, Bo, Zhang, Yue-Lun
Formato:	Journal Article
Publicado:	Springer Nature Aug2025
Acceso en línea:	Ver este registro en EBSCOhost